Circumferential trabecular meshwork cell density in the human eye.


Journal

Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707

Informations de publication

Date de publication:
04 2021
Historique:
received: 23 07 2020
revised: 04 02 2021
accepted: 09 02 2021
pubmed: 18 2 2021
medline: 4 9 2021
entrez: 17 2 2021
Statut: ppublish

Résumé

The cells residing in the trabecular meshwork (TM) fulfill important roles in the maintenance of the tissue and the regulation of intraocular pressure (IOP). Here we examine (i) TM cell distribution along the circumference of the human eye, (ii) differences in TM cell density between regions of high and low outflow, and (iii) whether TM cell distribution in eyes from donors with primary open angle glaucoma (POAG) differs from that of normal eyes. Toward this end, the TM cell density from 12 radial segments around the circumference of the TM of human donor eyes (n = 6) with and without POAG was determined using histochemical methods. Areas of high, median, and low outflow were mapped in a different set of human donor eyes that were perfused in organ culture, and TM cell densities in these areas were determined in normal (n = 11) and POAG eyes (n = 6). Our analysis of 1380 tissue sections taken from the first set of six eyes shows that the average TM cell density of these six eyes ranges from 15.5 to 23.7 cells/100 μm and is negatively correlated to the maximum IOP recorded for each donor eye (R

Identifiants

pubmed: 33596442
pii: S0014-4835(21)00059-2
doi: 10.1016/j.exer.2021.108494
pmc: PMC8044015
mid: NIHMS1675058
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

108494

Subventions

Organisme : RRD VA
ID : I01 RX001163
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026048
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY025580
Pays : United States
Organisme : RRD VA
ID : I50 RX003002
Pays : United States
Organisme : RRD VA
ID : I01 RX002860
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Références

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):1-7
pubmed: 15623746
Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1327-31
pubmed: 2365563
Exp Eye Res. 2016 May;146:354-360
pubmed: 26775054
Nat Commun. 2017 Nov 24;8(1):1755
pubmed: 29176626
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3492-500
pubmed: 27274060
Invest Ophthalmol Vis Sci. 2011 Apr 05;52(5):2147-52
pubmed: 21220561
Trans Ophthalmol Soc U K. 1976 Jul;96(2):245-55
pubmed: 1070878
Bull Soc Belge Ophtalmol. 1987;225 Pt 2:1-43
pubmed: 3077078
Invest Ophthalmol Vis Sci. 1987 Jun;28(6):945-53
pubmed: 3583633
Exp Eye Res. 2020 Jan;190:107888
pubmed: 31786158
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2054-2062
pubmed: 28384726
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):11
pubmed: 32645134
Stem Cells. 2015 Mar;33(3):751-61
pubmed: 25377070
Eye Vis (Lond). 2019 Oct 17;6:31
pubmed: 31641682
Invest Ophthalmol Vis Sci. 1988 Jan;29(1):90-100
pubmed: 3335436
Exp Eye Res. 2017 May;158:59-66
pubmed: 27498226
Arch Ophthalmol. 1988 Apr;106(4):544-7
pubmed: 3355425
Acta Biomater. 2018 Apr 15;71:444-459
pubmed: 29524673
Ophthalmology. 2011 Sep;118(9):1766-73
pubmed: 21600658
Sci Rep. 2020 Feb 19;10(1):2905
pubmed: 32076077
Exp Eye Res. 2016 Mar;144:29-37
pubmed: 26226231
Invest Ophthalmol Vis Sci. 1981 Nov;21(5):714-27
pubmed: 7298275
Invest Ophthalmol Vis Sci. 2011 Jul 07;52(8):5049-57
pubmed: 21596823
Jpn J Ophthalmol. 1987;31(4):558-69
pubmed: 3448324
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):173-81
pubmed: 25957840
Prog Mol Biol Transl Sci. 2015;134:301-14
pubmed: 26310162
Oncotarget. 2015 Jun 20;6(17):15362-74
pubmed: 25915531
J Glaucoma. 2006 Apr;15(2):142-51
pubmed: 16633228
Am J Ophthalmol. 1989 Jan 15;107(1):1-6
pubmed: 2912110
Exp Eye Res. 2017 May;158:3-12
pubmed: 27448987
PLoS One. 2015 Mar 31;10(3):e0122483
pubmed: 25826404
Ophthalmology. 1984 Jun;91(6):564-79
pubmed: 6462622
J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):213-23
pubmed: 24456518
Invest Ophthalmol Vis Sci. 1990 Jan;31(1):115-24
pubmed: 2298532
Nat Genet. 2014 Oct;46(10):1126-1130
pubmed: 25173106
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):246-259
pubmed: 29340639
Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3841-51
pubmed: 7928181
Am J Ophthalmol. 2018 Apr;188:51-59
pubmed: 29360458

Auteurs

Markus H Kuehn (MH)

Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, 52242, USA; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, 52246, USA. Electronic address: markus-kuehn@uiowa.edu.

Janice A Vranka (JA)

Casey Eye Institute, Oregon Health and Science University, Portland, OR, 97239, USA.

David Wadkins (D)

Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, 52242, USA; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, 52246, USA.

Thomas Jackson (T)

Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, 52242, USA; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, 52246, USA.

Lin Cheng (L)

Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, 52242, USA; Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, 52246, USA.

Johannes Ledolter (J)

Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, 52246, USA; Department of Statistics and Actuarial Science, The University of Iowa, Iowa City, IA, 52242, USA; Tippie College of Business, The University of Iowa, Iowa City, IA, 52242, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH